Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

WEBINAR: Cancer Drug Screening - Watch Now!
SUNDAY, FEBRUARY 28, 2016
linkedin twitter facebook |  55Shares

It’s a conundrum that cancer and pharma researchers know all too well: combination treatments tend to be most effective for cancer patients, but high-throughput screening for those combinations adds an unwanted level of complexity to the already challenging discovery process. Furthermore, while the industry has focused on tools to analyze the output from complex combinatorial screens, little attention has been given to tools that simplify the setup and management of creating screening plates.


Addressing these bottlenecks is the topic of a recent webinar from Genetic Engineering & Biotechnology News called , “Acoustic Liquid Handling Is Integral for Successful Cancer Drug Discovery,” featuring our Senior Product Marketing Manager Randy Dyer as well As Dr. Bruce Posner from the University of Texas Southwestern Medical Center.


Here’s how GEN sums it up: “With acoustic liquid handling, samples and reagents are rapidly transferred from any well of a library plate to any well of an assay plate in any arrangement, matrix, or layout necessary. Additionally the levels of miniaturization, precision, and accuracy achieved with acoustic liquid handling greatly lowers screening costs while increasing throughput — a significant boost of efficiency.”


Randy described the Echo® Liquid Handlers and the acoustic droplet ejection technology behind them. He also showcased our new software tool designed for combination screening of compounds, called Echo Combination Screen.


Dr. Posner spoke about the use of phenotypic and chemical screens to find new therapeutic approaches in the fight against cancer, and shared his experience with the Labcyte Access™ Laboratory Workstation for this work.